API5-FGF2 complex
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal Structure of API5-FGF2 Complex== | ==Crystal Structure of API5-FGF2 Complex== | ||
<StructureSection load='6L4O ' size='340' side='right' caption='Crystal structure of API5-FGF2 complex' scene=''> | <StructureSection load='6L4O ' size='340' side='right' caption='Crystal structure of API5-FGF2 complex' scene=''> | ||
| + | BI3323-Aug2025 | ||
{{Template:ClickGreenLinks}} | {{Template:ClickGreenLinks}} | ||
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | ||
| Line 6: | Line 7: | ||
== Functions of API5 and FGF2 == | == Functions of API5 and FGF2 == | ||
| - | Apoptosis, a highly regulated programmed cell death process, is important in maintaining tissue homeostasis and eliminating damaged or potentially abnormal cells. Various pro- and anti-apoptotic proteins regulate apoptosis. Api5, [[3v6a]],(Apoptosis Inhibitor 5) is an anti-apoptotic protein which is known to inhibit cell death by various methods, which includes Api5-FGF2 mediated [[Bim]] (pro-apoptotic protein) degradation<ref> DOI | + | <font color='maroon'>Apoptosis</font>, a highly regulated programmed cell death process, is important in maintaining tissue homeostasis and eliminating damaged or potentially abnormal cells. Various pro- and anti-apoptotic proteins regulate apoptosis. Api5, [[3v6a]],(Apoptosis Inhibitor 5) is an anti-apoptotic protein which is known to inhibit cell death by various methods, which includes Api5-FGF2 mediated [[Bim]] (pro-apoptotic protein) degradation <ref>DOI 10.3390/biom14010136</ref>. |
[[FGF2]] (Fibroblast Growth Factor 2) is a protein that helps regulate proliferation, cell differentiation, morphogenesis, wound healing, and various other cellular processes.<ref> https://doi.org/10.1210/edrv.18.1.0292</ref> FGF2 is produced in both low and high-molecular-weight isoforms, all translated from a single mRNA using alternative translation start sites. The low molecular weight (LMW) form, an 18 kDa protein, is synthesized from a conventional AUG codon. This isoform is distributed in the cytoplasm and nucleus and can also be secreted by cells. The high molecular weight (HMW) isoforms (22, 22.5, 24, 34 kDa) are generated by translation initiation at upstream CUG codons. | [[FGF2]] (Fibroblast Growth Factor 2) is a protein that helps regulate proliferation, cell differentiation, morphogenesis, wound healing, and various other cellular processes.<ref> https://doi.org/10.1210/edrv.18.1.0292</ref> FGF2 is produced in both low and high-molecular-weight isoforms, all translated from a single mRNA using alternative translation start sites. The low molecular weight (LMW) form, an 18 kDa protein, is synthesized from a conventional AUG codon. This isoform is distributed in the cytoplasm and nucleus and can also be secreted by cells. The high molecular weight (HMW) isoforms (22, 22.5, 24, 34 kDa) are generated by translation initiation at upstream CUG codons. | ||
== Disease and Biological Relevance== | == Disease and Biological Relevance== | ||
| - | Api5 is a predominantly nuclear protein that forms a complex with nuclear FGF2, | + | Api5 is a predominantly nuclear protein that forms a complex with nuclear FGF2, associated with clinical outcomes in cancer. The crystal structure of the Api5–FGF2 complex defines how these two proteins interact and identifies the specific residues involved in their binding. Subsequent analyses revealed an unanticipated function for the complex: Api5 and FGF2 associate with the essential RNA helicase UAP56, a core component of mRNA export pathways. Through this interaction, they contribute to the export and expression of select oncogenic mRNAs. |
Recent studies have shown that overexpression of Api5 in a non-tumorigenic breast epithelial cell line, increased the levels of FGF2 during the initial stages of morphogenesis and it also led to the activation of the Akt and ERK pathway during the initial and later stages of morphogenesis, respectivily. These findings establish Api5 and nuclear FGF2 as previously unrecognized factors in mRNA export and highlight their potential relevance to cancer biology. | Recent studies have shown that overexpression of Api5 in a non-tumorigenic breast epithelial cell line, increased the levels of FGF2 during the initial stages of morphogenesis and it also led to the activation of the Akt and ERK pathway during the initial and later stages of morphogenesis, respectivily. These findings establish Api5 and nuclear FGF2 as previously unrecognized factors in mRNA export and highlight their potential relevance to cancer biology. | ||
| Line 18: | Line 19: | ||
===Key Interaction Residues Revealed by Crystal Structure=== | ===Key Interaction Residues Revealed by Crystal Structure=== | ||
| - | The API5–FGF2 interface is dominated by electrostatic interactions, as supported by the surface charge patterns and the salt-sensitive reduction of binding. A total of twenty API5 residues and fourteen FGF2 residues make direct contact. Among them, <scene name='10/1096856/Api5_binding_residues/1'>seven</scene> highly conserved, mainly <font color='blue'>negatively charged</font> API5 residues: Asp145, Glu184, Asp185, Glu190, Glu219, Asp222, and Arg237, form <font color='orange'>hydrogen bonds</font> or <font color='orange'>salt bridges</font> with FGF2. These residues lie on the “convex” central region of API5 that links its HEAT (α1–α11) and ARM-like (α12–α19) helical repeats. | + | The API5–FGF2 interface is dominated by <font color='purple'>electrostatic interactions</font>, as supported by the surface charge patterns and the salt-sensitive reduction of binding. A total of twenty API5 residues and fourteen FGF2 residues make direct contact. Among them, <scene name='10/1096856/Api5_binding_residues/1'>seven</scene> highly conserved, mainly <font color='blue'>negatively charged</font> API5 residues: Asp145, Glu184, Asp185, Glu190, Glu219, Asp222, and Arg237, form <font color='orange'>hydrogen bonds</font> or <font color='orange'>salt bridges</font> with FGF2. These residues lie on the “convex” central region of API5 that links its HEAT (α1–α11) and ARM-like (α12–α19) helical repeats. |
<scene name='10/1096856/Fgf2_binding_residues/1'>Seven</scene> <font color='red'>positively charged</font> surface residues of FGF2: Asn169 in the β1–β2 loop, Arg223 in β7, Arg262 and Thr263 in the β10–β11 loop, Lys267 in β11, and Lys271 and Lys277 in the β11–β12 loop, form <font color='orange'>hydrogen bonds</font> or <font color='orange'>salt bridges</font> with Api5. | <scene name='10/1096856/Fgf2_binding_residues/1'>Seven</scene> <font color='red'>positively charged</font> surface residues of FGF2: Asn169 in the β1–β2 loop, Arg223 in β7, Arg262 and Thr263 in the β10–β11 loop, Lys267 in β11, and Lys271 and Lys277 in the β11–β12 loop, form <font color='orange'>hydrogen bonds</font> or <font color='orange'>salt bridges</font> with Api5. | ||
Revision as of 10:14, 1 December 2025
Crystal Structure of API5-FGF2 Complex
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ doi: https://dx.doi.org/10.3390/biom14010136
- ↑ https://doi.org/10.1210/edrv.18.1.0292
